Wikipedia

Neurodegenerativna bolest

(Preusmjereno sa Neurodegeneracija)

Neuroegenerativna bolest je posljedica kontinuiranog procesa zasnovanog na degenerativnim promjenama ćelija, koje zahvataju tkiva ili organi, koji će se vremenom sve više pogoršavati.[2]

Neurodegenerativna bolest
Normalan mozak (lijevo) u poređenju sa strukturnim promjenama prikazanim u mozgu osobe s Alzheimerovom bolešću, najčešćom neurodegenrativnom bolešću (desno).[1]
SpecijalnostNeurologija, psihijatrija

Kod neurodegenerativnih bolesti, ćelije centralnog nervnog sistema prestaju da rade ili umiru putem neurodegeneracija. Primjer za to je Alzheimerova bolest.[3] Druge dvije uobičajene grupe degenerativnih bolesti su one koje pogađaju cirkulacijski sistem (npr. koronarne arterijske bolesti) i neoplazijske bolesti (npr. kancer)i.[2]

Postoje mnoge degenerativne bolesti, a neke su povezane sa starenjem. Normalno tjelesno ponašanje ili izbor načina života (kao što su vježbanje ili prehrambene navike) mogu pogoršati degenerativne bolesti, ali to ovisi o bolesti.[2] Ponekad je glavni ili djelimični uzrok takvih bolesti genetički.[4] Stoga su neki očito nasljedni kao Huntingtonova bolest.[5] Ponekad su uzrok virusi, otrovi ili druge hemikalije. Uzrok također može biti nepoznat.[4]

Neke degenerativne bolesti mogu se izliječiti, ali ne uvijek. Još uvijek je moguće ublažavanje simptoma.[2]

Primjeri

uredi

Također pogledajte

uredi

Reference

uredi
  1. ^ Erkkinen, Michael G.; Kim, Mee-Ohk; Geschwind, Michael D (april 2018). "Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases". Cold Spring Harbor Perspectives in Biology. 10 (4): 20. doi:10.1101/cshperspect.a033118. PMC 5880171.
  2. ^ a b c d e "What is Degenerative Disease". docdoc.com.sg. Arhivirano s originala, 17. 9. 2018. Pristupljeno 17. 9. 2018.
  3. ^ "neurodegenerative disorder". National Cancer Institute. 2. 2. 2011. Arhivirano s originala, 23. 4. 2018. Pristupljeno 17. 9. 2018.
  4. ^ a b "Neurodegenerative Diseases". Arhivirano s originala, 28. 7. 2018. Pristupljeno 17. 9. 2018.
  5. ^ a b Nopoulos, PC (2016). "Huntington disease: a single-gene degenerative disorder of the striatum". Dialogues in Clinical Neuroscience. 18 (1): 91–98. doi:10.31887/DCNS.2016.18.1/pnopoulos. ISSN 1294-8322. PMC 4826775. PMID 27069383.
  6. ^ a b c d Soto, C; Satani, N (2011). "The intricate mechanisms of neurodegeneration in prion diseases". Trends in Molecular Medicine. 17 (1): 14–24. doi:10.1016/j.molmed.2010.09.001. ISSN 1471-4914. PMC 3056171. PMID 20889378.
  7. ^ Patzkó, Á; Shy, ME (2011). "Update on Charcot-Marie-Tooth Disease". Current Neurology and Neuroscience Reports. 11 (1): 78–88. doi:10.1007/s11910-010-0158-7. ISSN 1528-4042. PMC 3685483. PMID 21080241.
  8. ^ Maroon, JC; Winkelman, R; Bost, J; Amos, A; Mathyssek, C; Miele, V (11. 2. 2015). "Chronic Traumatic Encephalopathy in Contact Sports: A Systematic Review of All Reported Pathological Cases". PLOS ONE. 10 (2): e0117338. Bibcode:2015PLoSO..1017338M. doi:10.1371/journal.pone.0117338. ISSN 1932-6203. PMC 4324991. PMID 25671598.
  9. ^ Fraser-Pitt, D; O’Neil, D (2015). "Cystic fibrosis – a multiorgan protein misfolding disease". Future Science OA. 1 (2): FSO57. doi:10.4155/fso.15.57. ISSN 2056-5623. PMC 5137970. PMID 28031875.
  10. ^ "Cytochrome c oxidase deficiency". rarediseases.info.nih.gov. Arhivirano s originala, 22. 10. 2017. Pristupljeno 17. 9. 2018.
  11. ^ "Ehlers-Danlos syndromes". rarediseases.info.nih.gov. Arhivirano s originala, 16. 6. 2018. Pristupljeno 17. 9. 2018.
  12. ^ Delatycki, M; Williamson, R; Forrest, S (2000). "Friedreich ataxia: an overview". Journal of Medical Genetics. 37 (1): 1–8. doi:10.1136/jmg.37.1.1. ISSN 0022-2593. PMC 1734457. PMID 10633128.
  13. ^ Warren, JD; Rohrer, JD; Rossor, MN (6. 8. 2013). "Frontotemporal dementia". The BMJ. 347: f4827. doi:10.1136/bmj.f4827. ISSN 0959-8138. PMC 3735339. PMID 23920254.
  14. ^ Barik, R (2016). "Degenerative aortic valve disease and coronary artery disease are either side of a coin". Indian Heart Journal. 68 (3): 432. doi:10.1016/j.ihj.2015.09.010. ISSN 0019-4832. PMC 4911461. PMID 27316510.
  15. ^ Li, H; Zou, Y; Bao, X; Wang, H; Wang, J; Jin, H; Che, Y; Tang, X (2016). "Monozygotic twins with infantile neuroaxonal dystrophy: A case report and literature review". Experimental and Therapeutic Medicine. 12 (5): 3387–3389. doi:10.3892/etm.2016.3761. ISSN 1792-0981. PMC 5103811. PMID 27882168.
  16. ^ Davidson, AE; Hayes, S; Hardcastle, AJ; Tuft, SJ (2014). "The pathogenesis of keratoconus". Eye. 28 (2): 189–195. doi:10.1038/eye.2013.278. ISSN 0950-222X. PMC 3930280. PMID 24357835.
  17. ^ Wallang, BS; Das, S (2013). "Keratoglobus". Eye. 27 (9): 1004–1012. doi:10.1038/eye.2013.130. ISSN 0950-222X. PMC 3772364. PMID 23807384.
  18. ^ van der Knaap, MS; Bugiani, M (2017). "Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms". Acta Neuropathologica. 134 (3): 351–382. doi:10.1007/s00401-017-1739-1. ISSN 0001-6322. PMC 5563342. PMID 28638987.
  19. ^ Anand, A; Sharma, K; Chen, W; Sharma, NK (2014). "Using Current Data to Define New Approach in Age Related Macular Degeneration: Need to Accelerate Translational Research". Current Genomics. 15 (4): 266–277. doi:10.2174/1389202915666140516204512. ISSN 1389-2029. PMC 4133950. PMID 25132797.
  20. ^ Gao, L; Luo, F; Hui, R; Zhou, X (2010). "Recent molecular biological progress in Marfan syndrome and Marfan-associated disorders". Ageing Research Reviews (jezik: engleski). 9 (3): 363–368. doi:10.1016/j.arr.2009.09.001. ISSN 1568-1637. PMID 19772952. S2CID 205666350.
  21. ^ "MELAS Syndrome". NORD (National Organization for Rare Disorders). Arhivirano s originala, 20. 2. 2017. Pristupljeno 17. 9. 2018.
  22. ^ El-Hattab, AW; Scaglia, F (2013). "Mitochondrial DNA Depletion Syndromes: Review and Updates of Genetic Basis, Manifestations, and Therapeutic Options". Neurotherapeutics. 10 (2): 186–198. doi:10.1007/s13311-013-0177-6. ISSN 1933-7213. PMC 3625391. PMID 23385875.
  23. ^ Fitzner, D; Simons, M (2010). "Chronic Progressive Multiple Sclerosis – Pathogenesis of Neurodegeneration and Therapeutic Strategies". Current Neuropharmacology. 8 (3): 305–315. doi:10.2174/157015910792246218. ISSN 1570-159X. PMC 3001222. PMID 21358979.
  24. ^ Ubhi, K; Low, P; Masliah, E (2011). "Multiple System Atrophy: A Clinical and Neuropathological Perspective". Trends in Neurosciences. 34 (11): 581–590. doi:10.1016/j.tins.2011.08.003. ISSN 0166-2236. PMC 3200496. PMID 21962754.
  25. ^ Shin, J; Tajrishi, MM; Ogura, Y; Kumar, A (2013). "Wasting Mechanisms in Muscular Dystrophy". The International Journal of Biochemistry & Cell Biology. 45 (10): 2266–2279. doi:10.1016/j.biocel.2013.05.001. ISSN 1357-2725. PMC 3759654. PMID 23669245.
  26. ^ Mole, SE; Williams, Ruth E. (1993), Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E. (ured.), "Neuronal Ceroid-Lipofuscinoses", GeneReviews®, University of Washington, Seattle, PMID 20301601, pristupljeno 17. 9. 2018
  27. ^ Evans, WRH; Hendriksz, CJ (2017). "Niemann–Pick type C disease – the tip of the iceberg? A review of neuropsychiatric presentation, diagnosis and treatment". BJPsych Bulletin. 41 (2): 109–114. doi:10.1192/pb.bp.116.054072. ISSN 2056-4694. PMC 5376728. PMID 28400970.
  28. ^ a b Shen, Y; Zhang, Y; Shen, L (15. 4. 2013). "Postmenopausal women with osteoporosis and osteoarthritis show different microstructural characteristics of trabecular bone in proximal tibia using high-resolution magnetic resonance imaging at 3 tesla". BMC Musculoskeletal Disorders. 14: 136. doi:10.1186/1471-2474-14-136. ISSN 1471-2474. PMC 3659090. PMID 23587336.
  29. ^ Bazan, IS; Fares, WH (17. 8. 2015). "Pulmonary hypertension: diagnostic and therapeutic challenges". Therapeutics and Clinical Risk Management. 11: 1221–1233. doi:10.2147/TCRM.S74881. ISSN 1176-6336. PMC 4544628. PMID 26316767.
  30. ^ Owolabi, LF (2013). "Progressive Supranuclear Palsy Misdiagnosed as Parkinson's Disease: A Case Report and Review of Literature". Annals of Medical and Health Sciences Research. 3 (Suppl1): S44–S47. doi:10.4103/2141-9248.121221. ISSN 2141-9248. PMC 3853608. PMID 24349849.
  31. ^ Hamel, C (11. 10. 2006). "Retinitis pigmentosa". Orphanet Journal of Rare Diseases. 1: 40. doi:10.1186/1750-1172-1-40. ISSN 1750-1172. PMC 1621055. PMID 17032466.
  32. ^ Abdel-Ahad, P; El Chammai, M; Fneich, A; Issa, R; Kabbara, W; Richa, S (2016). "Les manifestations psychiatriques dans la polyarthrite rhumatoïde". L'Encéphale. 42 (2): 172–176. doi:10.1016/j.encep.2015.12.008. ISSN 0013-7006. PMID 26850214.
  33. ^ a b Walia, JP; Altaleb, N; Bello, A; Kruck, C; LaFave, MC; Varshney, GK; Burgess, SM; Chowdhury, B; Hurlbut, D (2015). "Long-Term Correction of Sandhoff Disease Following Intravenous Delivery of rAAV9 to Mouse Neonates". Molecular Therapy. 23 (3): 414–422. doi:10.1038/mt.2014.240. ISSN 1525-0016. PMC 4351464. PMID 25515709.
  34. ^ Simone, C; Ramirez, A; Bucchia, M; Rinchetti, P; Rideout, H; Papadimitriou, D; Re, DB; Corti, S (2016). "Is Spinal Muscular Atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?". Cellular and Molecular Life Sciences. 73 (5): 1003–1020. doi:10.1007/s00018-015-2106-9. ISSN 1420-682X. PMC 4756905. PMID 26681261.
  35. ^ Jafri, SK; Kumar, R; Ibrahim, SH (26. 6. 2018). "Subacute sclerosing panencephalitis – current perspectives". Pediatric Health, Medicine and Therapeutics. 9: 67–71. doi:10.2147/PHMT.S126293. ISSN 1179-9927. PMC 6027681. PMID 29985487.
  36. ^ "Brain Disease Model of Drug & Alcohol Addiction | Hazelden Betty Ford". Arhivirano s originala, 27. 10. 2017.
  37. ^ Korczyn, AD; Vakhapova, V; Grinberg, LT (15. 11. 2012). "Vascular dementia". Journal of the Neurological Sciences. 322 (1–2): 2–10. doi:10.1016/j.jns.2012.03.027. ISSN 0022-510X. PMC 3435447. PMID 22575403.

Vanjski linkovi

uredi

Šablon:Dugovječnost

Preuzeto iz "https://bs.wikipedia.org/w/index.php?title=Neurodegenerativna_bolest&oldid=3494936"